Page last updated: 2024-08-23

etoposide and Atrial Fibrillation

etoposide has been researched along with Atrial Fibrillation in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frikha, M; Khanfir, A; Kridis, WB; Triki, F	1
Guglin, M; Haq, M; Patel, A	1
Abboud, CN; Becker, MW; Bernstein, SH; Constine, LS; Friedberg, JW; Ifthikharuddin, JJ; Liesveld, JL; Loughner, JE; Milner, LA; Phillips, GL; Vesole, DH	1
Hasson, NK; Le, AT; Lum, BL	1

Trials

1 trial(s) available for etoposide and Atrial Fibrillation

Article	Year
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7 Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Mucositis; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2011

Article

Year

A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7

Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Carmustine; Combined Modality Therapy; Cytarabine; Cytoprotection; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Mucositis; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Transplantation Conditioning; Transplantation, Autologous; Young Adult

2011

Other Studies

3 other study(ies) available for etoposide and Atrial Fibrillation

Article	Year
An exceptional case of atrial fibrillation arrhythmia induced by etoposide. Current drug safety, 2013, Volume: 8, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Atrial Fibrillation; Drug Monitoring; Etoposide; Humans; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms	2013
Cardiac lymphoma: sinus pauses disappear after chemotherapy. Annals of hematology, 2014, Volume: 93, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Cisplatin; Cytarabine; Etoposide; Female; Humans; Methylprednisolone; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sick Sinus Syndrome	2014
Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:9 Topics: Aged; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Carboplatin; Drug Interactions; Etoposide; Germinoma; Humans; Male; Mediastinal Neoplasms; Testicular Neoplasms; Warfarin	1997